How to buy DexCom (DXCM) shares in Australia
Learn how to easily invest in DexCom shares.
DexCom Inc (DXCM) is a leading medical devices business with stocks listed in the US. It opened the day at US$116.37 after a previous close of US$118.24. During the day the price has varied from a low of USD115.64 to a high of USD117.82. The latest price was USD117.2 (25 minute delay). DexCom is listed on the NASDAQ. All prices are listed in US Dollars.
How to buy shares in DexCom
- Compare share trading platforms. To buy shares in a company listed in the US from Australia you'll need to find a trading platform that offers access to US stock markets. Look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, which will typically include your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for DexCom. Find the share by name or ticker symbol: DXCM. Research its history to confirm it's a solid investment that matches your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until DexCom reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying using consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$118.24, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of DexCom, depending on your broker.
- Check in on your investment. Congratulations, you own a part of DexCom. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights.
What's in this guide?
- DexCom key stats
- Compare share trading platforms
- Is DexCom stock a buy or sell?
- DexCom performance over time
- Is DexCom suitable for ethical investing?
- Are DexCom shares over-valued?
- DexCom's financials
- How volatile are DexCom shares?
- Does DexCom pay a dividend?
- Have DexCom shares ever split?
- Other common questions
DexCom stock price (NASDAQ:DXCM)Use our graph to track the performance of DXCM stocks over time.
Have DexCom's shares ever split?
DexCom's shares were split on a 4:1 basis on 13 June 2022. So if you had owned 1 share the day before the split, the next day you would own 4 shares. This wouldn't directly have changed the overall worth of your DexCom shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for DexCom shares which in turn could have impacted DexCom's share price.
DexCom shares at a glance
|52-week range||US$74.75 - US$139.55|
|50-day moving average||US$93.621|
|200-day moving average||US$111.3725|
|Dividend yield||US$0 (0.41%)|
|Earnings per share (TTM)||US$0.92|
DexCom price performance over time
|1 week (2023-11-28)||4.46%|
|1 month (2023-11-03)||20.25%|
|3 months (2023-09-05)||16.81%|
|6 months (2023-06-05)||-5.98%|
|1 year (2022-12-05)||0.55%|
|2 years (2021-12-03)||-9.76%|
|3 years (2020-12-04)||34.70%|
|5 years (2018-12-06)||262.09%|
Compare trading platforms to buy DexCom shares
Is it a good time to buy DexCom stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is DexCom under- or over-valued?
Valuing DexCom stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DexCom's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DexCom's P/E ratio
DexCom's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 129x. In other words, DexCom shares trade at around 129x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
DexCom's PEG ratio
DexCom's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3891. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DexCom's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
DexCom's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$659.6 million (£0.0 million).
The EBITDA is a measure of a DexCom's overall financial performance and is widely used to measure stock profitability.
DexCom share price volatility
Over the last 12 months, DexCom's shares have ranged in value from as little as US$74.75 up to US$139.55. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DexCom's is 1.215. This would suggest that DexCom's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
|Revenue TTM||US$3.4 billion|
|Operating margin TTM||21.08%|
|Gross profit TTM||US$1.9 billion|
|Return on assets TTM||5.5%|
|Return on equity TTM||18.42%|
|Market capitalisation||US$45.1 billion|
TTM: trailing 12 months
DexCom share dividends
We're not expecting DexCom to pay a dividend over the next 12 months.
DexCom's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like DexCom.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
DexCom's total ESG risk score
Total ESG risk: 29.18
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and DexCom's overall score of 29.18 (as at 01/01/2019) is nothing to write home about – landing it in it in the 50th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like DexCom is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
DexCom's environmental score
Environmental score: 10.43/100
DexCom's environmental score of 10.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that DexCom is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
DexCom's social score
Social score: 17.04/100
DexCom's social score of 17.04 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that DexCom is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
DexCom's governance score
Governance score: 13.2/100
DexCom's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that DexCom is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
DexCom's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. DexCom scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that DexCom has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||29.18|
|Total ESG percentile||50.12|
|Environmental score percentile||6|
|Social score percentile||6|
|Governance score percentile||6|
|Level of controversy||2|
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Stocks similar to DexCom
Frequently asked questions
More guides on Finder
Shein IPO: How to invest in the Shein IPO
What you need to know about investing in Shein from Australia.
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
Tiger Brokers review for Australians
If you're thinking of trading stocks with Tiger Brokers, check out our review of this online broker's fees, safety and pros and cons first.
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
How to buy Caltex Australia shares
Steps to owning and managing Caltex Australia shares from .
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
The cheapest stock brokers in Australia (Dec 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
What is the money market?
Learn about the money market and everyday consumer money market products.
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
The best trading platforms in Australia
Follow these tips to find the best share trading platform for you.
Ask an Expert